Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) is a blank check company incorporated to pursue a business combination in the biotechnology and life sciences sector. Sponsored by Orion Biotech Opportunities LLC, the company completed its initial public offering in 2021 and has concentrated its search on targets with innovative therapeutic, diagnostic, or life sciences platform potential. The Form 10-Q filed with the Securities and Exchange Commission on November 10, 2022 reflects the company's status as an active development-stage SPAC continuing its evaluation of combination candidates. To access complete filing history, deal timelines, and analytics on ORIA and hundreds of other SPACs, sign up for full data access at SpacDesk.